Currently, there are 231.79M common shares owned by the public and among those 159.62M shares have been available to trade.
The company’s stock has a 5-day price change of -14.32% and 20.93% over the past three months. CELH shares are trading 33.02% year to date (YTD), with the 12-month market performance up to 150.30% higher. It has a 12-month low price of $28.10 and touched a high of $99.62 over the same period. CELH has an average intraday trading volume of 4.86 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -14.06%, -5.75%, and 20.12% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Celsius Holdings Inc (NASDAQ: CELH) shares accounts for 62.80% of the company’s 231.79M shares outstanding.
It has a market capitalization of $16.88B and a beta (3y monthly) value of 1.91. The stock’s trailing 12-month PE ratio is 92.48, while the earnings-per-share (ttm) stands at $0.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.13% over the week and 4.77% over the month.
Analysts forecast that Celsius Holdings Inc (CELH) will achieve an EPS of $Clean Harbors, Inc. for the current quarter, $194.16 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Celularity Inc. while analysts give the company a high EPS estimate of $Celcuity Inc.. Comparatively, EPS for the current quarter was $Creative Medical Technology Hol a year ago. Earnings per share for the fiscal year are expected to increase by 43.09%, and 40.07% over the next financial year.
Looking at the support for the CELH, a number of firms have released research notes about the stock. Maxim Group stated their Buy rating for the stock in a research note on April 01, 2024, with the firm’s price target at $100-$110. Wedbush coverage for the Celsius Holdings Inc (CELH) stock in a research note released on March 04, 2024 offered a Outperform rating with a price target of $90. Maxim Group was of a view on March 01, 2024 that the stock is Buy, while Maxim Group gave the stock Buy rating on February 02, 2024, issuing a price target of $65. BofA Securities on their part issued Neutral rating on January 19, 2024.
